08.06.2017 • NewsElaine Burridgekemipreservatives

Kemi Urges Review of Cosmetic Preservatives

(c) Niloo/Shutterstock
(c) Niloo/Shutterstock

The Swedish Chemicals Agency (Kemi) is calling for a review of certain preservatives that are approved under the EU cosmetics regulation, so that substances with problematic environmental or health properties can be restricted.

Since these chemicals were assessed, new knowledge has emerged that EU cosmetics legislation does not take into account, Kemi said, adding that while the use of preservatives that can cause problems to health and the environment is low in Sweden, it is important to ensure levels do not increase.

In a report submitted to the Swedish government, Kemi investigated 19 preservatives used in cosmetic products and has prioritized seven for review: chlorobutanol; p-chloro-m-cresol; chloroxylenol; bromochlorophene; chlorophene; chlorhexidine and dichlorobenzyl alcohol. 

In its assessment, the agency found that seven of the preservatives it investigated have a high potential to cause allergies. With regard to contact dermatitis, Kemi said it is especially important to reduce exposure to the commonly used mixture of methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI).

It is also calling for restrictions on preservatives such as triclosan and mercury because their frequent use is suspected to contribute to antibiotic resistance.

Kemi said the most problematic substances should be restricted through the EU’s REACH chemical regulation rather than through the introduction of Swedish national legislation on cosmetic products.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.